Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer

RT @JournalofExper1: New! 💥 𝐁𝐥𝐨𝐜𝐤𝐚𝐝𝐞 of 𝐠𝐥𝐮𝐭𝐚𝐦𝐢𝐧𝐞-𝐝𝐞𝐩𝐞𝐧𝐝𝐞𝐧𝐭 𝐜𝐞𝐥𝐥 𝐬𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐚𝐮𝐠𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐭𝐢𝐭𝐮𝐦𝐨𝐫 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 of CPI-613 in #𝐡𝐞𝐚𝐝𝐚𝐧𝐝𝐧𝐞𝐜𝐤𝐜𝐚𝐧𝐜𝐞𝐫 Re…

𝐁𝐥𝐨𝐜𝐤𝐚𝐝𝐞 of 𝐠𝐥𝐮𝐭𝐚𝐦𝐢𝐧𝐞-𝐝𝐞𝐩𝐞𝐧𝐝𝐞𝐧𝐭 𝐜𝐞𝐥𝐥 𝐬𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐚𝐮𝐠𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐭𝐢𝐭𝐮𝐦𝐨𝐫 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 of CPI-613 in #𝐡𝐞𝐚𝐝𝐚𝐧𝐝𝐧𝐞𝐜𝐤𝐜𝐚𝐧𝐜𝐞𝐫

New! 💥 𝐁𝐥𝐨𝐜𝐤𝐚𝐝𝐞 of 𝐠𝐥𝐮𝐭𝐚𝐦𝐢𝐧𝐞-𝐝𝐞𝐩𝐞𝐧𝐝𝐞𝐧𝐭 𝐜𝐞𝐥𝐥 𝐬𝐮𝐫𝐯𝐢𝐯𝐚𝐥 𝐚𝐮𝐠𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐭𝐢𝐭𝐮𝐦𝐨𝐫 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 of CPI-613 in #𝐡𝐞𝐚𝐝𝐚𝐧𝐝𝐧𝐞𝐜𝐤𝐜𝐚𝐧𝐜𝐞𝐫 Read more⏬ https://t.co/GX0nBYjgVw #Glutaminolysis #Metabolism @IREISGufficiale https://t.co/y6yX18cMTC